Clinical Trials Directory

Trials / Terminated

TerminatedNCT00596544

Sexual Functioning After Primary Treatment of Ovarian Cancer

Status
Terminated
Phase
Study type
Observational
Enrollment
18 (actual)
Sponsor
Memorial Sloan Kettering Cancer Center · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to help us learn more about sexual problems after treatment for ovarian cancer. At this time, we do not know how many women have sexual problems after they are treated for ovarian cancer. How common are sexual problems after treatment for ovarian cancer? * What factors make women more likely to have sexual problems after treatment for ovarian cancer? * What happens to sexual functioning over the first 12 months after treatment? ie. Does it get better or worse? • Does referral to a specialized sexual health clinic help?

Conditions

Interventions

TypeNameDescription
BEHAVIORALquestionnaireswill be offered referral to the Sexual Health Clinic (SHC) at MSKCC for evaluation and possible treatment. The effectiveness and compliance of the intervention offered at the SHC will be assessed at approximately 3, 6 and 12 months using the FSFI, SAQ, CES-D, MSC and IES. At each evaluation they will complete a Health Surveillance Form (HSF). They will have completed the study at 12 months after entering the study or at the time they have evidence of recurrent disease requiring treatment
BEHAVIORALquestionnairesThose women who have a FSFI score \> 26 will be reassessed at approximately 3, 6 and 12 months. They will complete the FSFI, SAQ, CES-D, IES, MSC and HSF at each assessment. They will be followed out until 12 months after entering the study or until they have evidence of recurrent disease.

Timeline

Start date
2004-11-01
Primary completion
2015-11-01
Completion
2015-11-01
First posted
2008-01-17
Last updated
2015-11-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00596544. Inclusion in this directory is not an endorsement.